# The Phoenix Review: $879 for an Investigational Therapy, Self-Administered

> The trials used focused shockwaves from clinic machines under an operator. This is a handheld you point at yourself. The FDA has not cleared it for erectile dysfunction, and the AUA calls the therapy investigational.

- **Source:** ED Treatment Guides (https://www.edtreatmentguides.com/the-phoenix-reviews/phoenix-device)
- **Last updated:** 2026-08-02
- **Type:** product
- **Sold by:** The Phoenix
- **Product:** Acoustic wave device
- **Active ingredient:** No drug. A handheld device delivering acoustic pressure waves, intended to prompt new blood vessel growth in penile tissue
- **Regulatory status:** Not FDA-cleared for ED
- **Doses available:** One device with applicator heads; Self-administered protocol of repeated home sessions
- **Editorial rating:** 2.6/5
- **Best for:** Very few people. Men with confirmed vasculogenic ED who have exhausted evidence-based options and can afford to lose $879.
- **Closest equivalent elsewhere:** $879, against roughly twenty years of generic tadalafil or two medical-grade vacuum devices
- **Website:** https://www.getmyphoenix.com/
- **Commercial relationship:** No commercial relationship. Links to this product earn us nothing.

## Key points

- **Not FDA-cleared to treat erectile dysfunction**, whatever the phrase 'within FDA-cleared ranges' is doing in the marketing.
- The AUA guideline classes low-intensity shockwave therapy as **investigational** — for research protocols, not routine care.
- The trials used **focused shockwaves**; consumer handhelds generally produce **radial pressure waves**. Different physics, non-transferable evidence.
- **$879** with no clinician screening you for implants, bleeding disorders, Peyronie's or lesions.
- The same money buys roughly **twenty years of generic tadalafil**, which is guideline first-line treatment.

## Scores

| Criterion | Score | Note |
| --- | --- | --- |
| Clinical quality | 2/5 | Low-intensity shockwave therapy for ED is investigational — the AUA guideline says it belongs under research protocols. That is the clinic version. The consumer version compounds it: the trials used focused shockwaves at controlled energy delivered by a trained operator, and a handheld is not that machine. |
| Transparency | 2/5 | Language about output staying 'within FDA-cleared ranges for acoustic therapy' is built to be heard as clearance for treating ED. It is not one. That fact belongs on the first screen, not in a footnote — and the focused-versus-radial distinction is never addressed at all. |
| Value | 2.2/5 | $879, or around $704 on promotion, with financing at roughly $29–$43 a month. Cheaper than a course of in-office sessions, which is the comparison the marketing invites — but that only counts if the two deliver the same treatment, and the evidence that they do is absent. |
| Experience | 3.5/5 | The hardware is reportedly well made and the protocol is straightforward to follow at home, which is the entire product concept. Marked down because ease of self-administration is a thin virtue when nobody has established what should be self-administered. |
| Privacy | 4/5 | A one-off purchase of a physical object. No questionnaire, no prescriber, no health record, no subscription. The exposure is an $879 line on a statement and a marketing email address. |

**Overall: 2.6/5**

## Pros

- One-off purchase, cheaper than a course of in-office shockwave sessions
- No drugs, so no interactions — including none with nitrates
- Reusable indefinitely, so per-use cost falls over time
- No prescription, consultation or subscription
- The underlying idea — prompting new blood vessel growth — is a legitimate research direction

## Cons

- **Not FDA-cleared to treat erectile dysfunction.** 'Within FDA-cleared ranges' is not the same claim
- **The AUA guideline classes low-intensity shockwave therapy as investigational**, to be used under research protocols
- Consumer handhelds generally produce **radial pressure waves**, not the **focused shockwaves** used in the trials
- $879 with nobody assessing whether you are even a candidate
- Unlikely to help post-surgical or severe neurogenic ED, where the mechanism does not apply
- Contraindications — implants, bleeding disorders, Peyronie's, lesions — are screened by nobody
- The money buys roughly twenty years of a treatment that is guideline first-line

## Pricing

| Plan | Price | Includes |
| --- | --- | --- |
| The Phoenix | About $879 | Device, applicator heads, instructions. One-off purchase |
| On promotion | Around $704 | Frequently discounted. Financing quoted around $29–$43 a month |
| In-office shockwave, for scale | $400–$600 per session, usually six or more | Focused shockwaves, trained operator, clinical assessment. Still investigational, rarely covered |
| Generic tadalafil, for scale | About $20–$40 for 90 days | Guideline first-line, strong evidence, roughly 1/40th the price |

_Prices checked 2026-08-02. Verify on the provider's own site before ordering._

## Verdict

This is the lowest score on the site, and the reason is a stack of gaps that each sound survivable and are not. Start with the therapy itself. Low-intensity shockwave treatment for erectile dysfunction is not established care — the AUA guideline places it in the investigational category and advises it be offered under research protocols, because although the mechanism is plausible, the trials are small, short, inconsistent in protocol, and weaker when properly sham-controlled. That is the evidence for the clinic version, delivered by a trained operator with a machine costing thousands. Now the technical point the marketing never addresses: those studies used **focused shockwaves**, generated and aimed to deposit a defined energy density at a defined depth. Consumer handhelds in this price bracket generally produce **radial pressure waves**, which spread from the surface and lose energy rapidly with depth. They are different physical phenomena, and evidence for one is not evidence for the other. Then the regulatory layer. The Phoenix is not FDA-cleared to treat erectile dysfunction. Copy about energy output staying 'within safe, FDA-cleared ranges for acoustic therapy' is a sentence engineered to be heard as clearance without ever making the claim. Add it up: $879, spent with nobody assessing whether you are a candidate or whether an implant, a bleeding disorder or Peyronie's rules you out, on a home version of a therapy still investigational in clinics. If you have genuinely exhausted the evidence-based options, understand exactly what you are buying, and can lose the money without it mattering, that is your call to make and we are not going to pretend otherwise. For nearly everyone else, $879 is about twenty years of generic tadalafil.

## The premise, which is not stupid

Start with what is genuinely appealing here, because the pitch is not nonsense and the review would be unfair without it. Almost every ED treatment manages the symptom: a tablet dilates vessels for a few hours, a pump produces an erection now, a ring holds one. None changes the underlying tissue. The proposition behind shockwave therapy is that acoustic energy applied to penile tissue triggers a healing response including angiogenesis — the growth of new blood vessels. If that worked reliably it would be the first widely available treatment that repaired the plumbing rather than working around it.

That is a real research direction with published studies behind it, and our [shockwave therapy page](https://www.edtreatmentguides.com/treatments/shockwave-therapy) sets out where the evidence stands. In short: some trials show benefit, concentrated in men with vasculogenic ED who still respond partially to PDE5 inhibitors; the studies are mostly small and short with inconsistent protocols; sham-controlled results are weaker than open-label ones; and durability beyond a year is poorly established.

> **What the guideline says**
>
> The AUA's erectile dysfunction guideline treats low-intensity shockwave therapy as **investigational** and advises it be used under research protocols. That is not a dismissal — it is a statement that the evidence is not yet good enough to recommend as care. Everything below follows from it, because a home device cannot have better evidence than the clinical procedure it imitates.

## Focused versus radial: the distinction that decides it

'Shockwave' and 'acoustic wave' are used interchangeably in marketing. In physics, and in the trials, they are not interchangeable — and this is the single most useful thing on this page.

**Two different things sold under similar names**

|  | Focused shockwave | Radial pressure wave |
| --- | --- | --- |
| How it is generated | Electrohydraulic, electromagnetic or piezoelectric, then focused to a point | A projectile striking an applicator, spreading outward from the surface |
| Energy at depth | Concentrated at a defined focal depth | Highest at the skin, falling away rapidly with depth |
| Used in the published ED trials | Yes | Largely not |
| Typical setting | Clinic, trained operator, machine costing thousands | Consumer handhelds and physiotherapy massage guns |

_Manufacturers do not reliably state which type their device produces. If a product page does not say plainly, that omission is informative._

> **The question to put to any seller**
>
> "Is this focused or radial, and what energy density does it deliver at what depth?" A company with a defensible product answers directly. An answer that redirects to testimonials, or to studies of a different machine, is itself the answer.

If the mechanism depends on delivering particular energy to tissue at depth, and a device delivers something weaker that dissipates near the surface, trials of the first tell you very little about the second. The marketing bridges that gap by discussing shockwave therapy in general and then selling a handheld. The evidence does not bridge it.

## What the FDA has and has not said

> **Not cleared for erectile dysfunction**
>
> No low-intensity shockwave device is FDA-approved or cleared specifically to treat erectile dysfunction in the United States — that includes the machines used in clinics and it includes this one. Marketing saying energy output stays 'within safe, FDA-cleared ranges for acoustic therapy' is constructed to sound like clearance for this use. It is not one.

This matters beyond pedantry. Clearance for an indication is the mechanism by which somebody outside the company checks that a claimed benefit is supported. Without it, the only quality control on the claim is the company making it. When a device is sold for a use it has not been authorised for, you are the trial — and you are paying to be in it.

> **Nobody is screening you**
>
> Do not self-administer acoustic energy if you have a penile implant, an active infection, an untreated bleeding disorder, are on anticoagulants without advice, have [Peyronie's disease](https://www.edtreatmentguides.com/causes/peyronies-disease) or any unassessed penile lesion, or have a cancer diagnosis involving the area. A website that sells to anyone with a card is not going to establish which of those apply to you — and that absence is precisely the risk.

## Where the $879 could go instead

Opportunity cost is the strongest argument here — stronger than any objection to the hardware. Money spent on an investigational home treatment is money not spent on options with settled evidence, and in this field the proven ones are cheap.

**What $879 buys elsewhere**

| Instead | Roughly | Evidence |
| --- | --- | --- |
| Generic tadalafil, daily, for years | $20–$40 per 90 days | Strong — guideline first-line |
| Medical-grade vacuum device | $130 one-off | Strong — around 90% achieve a usable erection |
| Urology consultation and workup | $150–$400 cash | Finds the cause rather than guessing at it |
| Sex therapy, several sessions | $100–$250 each | Strong for psychogenic and mixed ED |
| Pelvic floor physiotherapy | $80–$200 per session | Randomised trial evidence, particularly for venous leak |

_US cash prices, which vary widely. Model your own with the [cost calculator](https://www.edtreatmentguides.com/tools/cost-calculator)._

> **If you still want to try shockwave**
>
> Do it the way the evidence was generated: in a clinic, with focused shockwaves, after a urologist has established that your ED is vasculogenic — the subgroup where the published benefit sits. It costs more and remains investigational, but at least it is the thing that was studied and someone qualified decides whether you are a candidate. Better still, ask about enrolling in a trial through [ClinicalTrials.gov](https://clinicaltrials.gov/).

## The narrow case for buying one anyway

We are not going to pretend nobody should ever buy this. There is a narrow set of circumstances where it is a defensible decision, and stating them is fairer than leaving the page as a wall of objections.

- You have **vasculogenic ED** confirmed by a clinician, rather than post-surgical nerve damage or a hormonal cause. That is the only group the published benefit has appeared in.
- You have already tried PDE5 inhibitors — they help partially, or you cannot take them.
- You understand that you are buying something investigational, and will not conclude that treatment has failed you when it does not work.
- **$879 is money you can lose**, not money moved from something you need.
- You have told a clinician you are doing it, so it is on your record if a problem arises.

> **And if you buy one, keep the alternatives running**
>
> The worst outcome here is not wasting $879. It is spending six months on an unproven device instead of getting assessed, while the vascular disease that erectile dysfunction frequently signals goes unexamined. Book the appointment either way — our guide on [talking to your doctor](https://www.edtreatmentguides.com/guides/talking-to-your-doctor) makes it easier than you expect.

## Frequently asked questions

### Is The Phoenix FDA approved?

No. No low-intensity shockwave device is FDA-approved or cleared to treat erectile dysfunction in the US, including clinic machines. Language about staying 'within FDA-cleared ranges for acoustic therapy' is not a clearance for treating ED, and it is worded to be heard as one.

### Does at-home shockwave therapy work for ED?

There is no good evidence that a consumer handheld does. The trials used focused shockwaves delivered by clinic machines, and even that use is classed as investigational by the AUA. Consumer devices generally produce radial pressure waves, which are physically different and lose energy near the surface, so the trial results do not transfer.

### How much does it cost?

About $879, frequently discounted to around $704, with financing quoted at roughly $29 to $43 a month. One-off purchase with nothing recurring.

### Is it cheaper than going to a clinic?

Yes — in-office sessions run $400 to $600 each and a course is usually six or more. But that comparison assumes both deliver the same treatment, and the evidence that a handheld matches a focused clinical device is missing. A cheaper version of an unproven therapy is not a bargain.

### Who should not use it?

Anyone with a penile implant, an active infection, a bleeding disorder or on anticoagulants without advice, Peyronie's disease or an unassessed penile lesion, or a cancer diagnosis involving the area. Nobody in this purchase screens for any of that, which is the core problem with the model.

### Will it cure my ED permanently?

Nothing on this site cures ED permanently, and durability of shockwave benefit beyond a year is poorly established even in the clinical studies. Treat permanent-cure claims with scepticism wherever you meet them.

### What should I do instead?

Get assessed, because ED is often the first sign of vascular disease. Then work through the options with settled evidence — PDE5 inhibitors, a vacuum device, pelvic floor training, sex therapy, and treating the underlying cause. All cost less than $879 and all have better evidence.

## Sources

- American Urological Association. [Erectile Dysfunction: AUA Guideline](https://www.auanet.org/guidelines-and-quality/guidelines/erectile-dysfunction-(ed)-guideline) (2018)
- U.S. Food and Drug Administration. [Device registration and listing — what it does and does not mean](https://www.fda.gov/medical-devices/how-study-and-market-your-device/device-registration-and-listing)
- National Library of Medicine. [ClinicalTrials.gov — find studies you can join](https://clinicaltrials.gov/)
- National Library of Medicine. [PubMed — search the primary literature](https://pubmed.ncbi.nlm.nih.gov/)
- Federal Trade Commission. [Health Products Compliance Guidance](https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance)

## Related pages

- [The Phoenix Review: $879 for a Therapy the FDA Has Not Cleared](https://www.edtreatmentguides.com/the-phoenix-reviews)
- [Shockwave Therapy for ED: What the Evidence Actually Shows](https://www.edtreatmentguides.com/treatments/shockwave-therapy)
- [Shockwave vs PRP: Comparing Two Treatments You Probably Should Not Buy](https://www.edtreatmentguides.com/compare/shockwave-vs-prp)
- [What to Do When ED Medication Doesn't Work](https://www.edtreatmentguides.com/guides/when-medication-fails)
- [Vacuum Erection Devices: How Penis Pumps Actually Work](https://www.edtreatmentguides.com/treatments/vacuum-erection-device)

---

_This page is general health information, not medical advice. It cannot account for your own history, medications or risk factors. Talk to a licensed clinician before starting, stopping or changing any treatment._

_Canonical URL: https://www.edtreatmentguides.com/the-phoenix-reviews/phoenix-device — HTML for people, Markdown for agents._